Zevra Therapeutics, Inc. (ZVRA)
12.01
-0.05
(-0.41%)
USD |
NASDAQ |
Sep 11, 16:00
12.00
-0.01
(-0.08%)
After-Hours: 20:00
Zevra Therapeutics Price to Book Value : 3.274 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 3.274 |
| September 10, 2026 | 3.288 |
| September 09, 2026 | 3.283 |
| September 08, 2026 | 3.456 |
| September 04, 2026 | 3.381 |
| September 03, 2026 | 3.419 |
| September 02, 2026 | 3.354 |
| September 01, 2026 | 3.288 |
| August 31, 2026 | 3.201 |
| August 28, 2026 | 3.153 |
| August 27, 2026 | 3.231 |
| August 26, 2026 | 3.201 |
| August 25, 2026 | 3.283 |
| August 24, 2026 | 3.176 |
| August 21, 2026 | 3.236 |
| August 20, 2026 | 3.242 |
| August 19, 2026 | 3.307 |
| August 18, 2026 | 3.154 |
| August 17, 2026 | 3.144 |
| August 14, 2026 | 3.086 |
| August 13, 2026 | 3.048 |
| August 12, 2026 | 3.119 |
| August 11, 2026 | 3.092 |
| August 10, 2026 | 3.13 |
| August 07, 2026 | 3.152 |
| Date | Value |
|---|---|
| August 06, 2026 | 3.239 |
| August 05, 2026 | 2.871 |
| August 04, 2026 | 2.868 |
| August 03, 2026 | 2.742 |
| July 31, 2026 | 2.593 |
| July 30, 2026 | 2.628 |
| July 29, 2026 | 2.666 |
| July 28, 2026 | 2.653 |
| July 27, 2026 | 2.647 |
| July 24, 2026 | 2.597 |
| July 23, 2026 | 3.414 |
| July 22, 2026 | 3.310 |
| July 21, 2026 | 3.394 |
| July 20, 2026 | 3.280 |
| July 17, 2026 | 3.482 |
| July 16, 2026 | 3.479 |
| July 15, 2026 | 3.534 |
| July 14, 2026 | 3.561 |
| July 13, 2026 | 3.594 |
| July 10, 2026 | 3.640 |
| July 09, 2026 | 3.801 |
| July 08, 2026 | 4.022 |
| July 07, 2026 | 3.937 |
| July 06, 2026 | 3.809 |
| July 02, 2026 | 3.812 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Innoviva, Inc. | 1.217 |
| Collegium Pharmaceutical, Inc. | 2.370 |
| Johnson & Johnson | 7.527 |
| Ligand Pharmaceuticals, Inc. | 5.857 |
| Harrow, Inc. | 85.03 |
Price to Book Value Related Metrics
| PE Ratio | 12.96 |
| PS Ratio | 5.243 |
| Price to Free Cash Flow | 21.87 |
| Price | 12.01 |
| Earnings Yield | 7.72% |
| Market Cap | 712.70M |
| Operating PE Ratio | 18.26 |
| Normalized PE Ratio | 10.59 |